Renal care companies develop business through vertical integration and innovative home care products
This article was originally published in Clinica
Executive Summary
Although dialysis technology has changed little over the years, companies are constantly developing new treatment techniques and solutions as the number of people suffering from end-stage renal disease (ESRD) continues to climb by an annual average of 8%. Some 800,000 people worldwide require dialysis treatment making a product market of about $6 billion with the cost of treatments worth approximately $23 billion, according to a new report published by Theta Reports, entitled Kidney dialysis equipment & supplies.
You may also be interested in...
California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits
The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.
Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer
Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025. It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.
Xaira Launches With $1bn-Plus And End-To-End AI Strategy
ARCH and Foresite incubated the company and recruited Genentech R&D veteran Marc Tessier-Lavigne to keep data generation, machine learning research and drug development under one roof.